Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Glaxo Wellcome identifies potential anxiolytic agents

Sep. 20, 1996

New CNS agents from American Cyanamid

Sep. 20, 1996

American Home Products investigates 5-HT1A antagonists for anxiety

Sep. 20, 1996

The effects of clonidine on sleep

Sep. 20, 1996

Combination analgesic progresses through clinical trials

Sep. 20, 1996

Post-surgical pain management with dynorphin A

Sep. 20, 1996

Ortho describes new analgesics

Sep. 20, 1996

Potential new analgesic agent from SmithKline Beecham

Sep. 20, 1996

Stroke Update

Sep. 13, 1996

Progress in CNS drug development at Daiichi

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...